Showing results (511-520 of 1,080) with videos related to
Sort By:
Pageof 108
Oncogene|July 12, 2005
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinomaGregory D Kirk, Olufunmilayo A Lesi, Maimuna Mendy, et al.Annals of Internal Medicine|February 27, 2013
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort studyGregory D Kirk, Shruti H Mehta, Jacquie Astemborski, et al.Medical Cannabis and Cannabinoids|December 5, 2022
Evaluations of Skin Permeability of Cannabidiol and Its Topical Formulations by Skin Membrane-Based Parallel Artificial Membrane Permeability Assay and Franz Cell Diffusion AssayRiley D Kirk, Toyosi Akanji, Huifang Li, et al.Plos One|August 30, 2019
Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adultsYingxi Chen, Martyn D Kirk, Rhonda Stuart, et al.The International Journal on Drug Policy|February 26, 2024
Longitudinal patterns of use of stimulants and opioids in the AIDS linked to the IntraVenous experience cohort, 2005-2019Jacqueline E Rudolph, Javier A Cepeda, Jacquie Astemborski, et al.JMIR Mhealth and Uhealth|March 17, 2016
Ecological Momentary Assessment of Illicit Drug Use Compared to Biological and Self-Reported MethodsBeth S Linas, Andrew Genz, Ryan P Westergaard, et al.Annals of Vascular Surgery|July 20, 2005
Midterm follow-up of inflammatory abdominal aortic aneurysms following endovascular repairRumi Faizer, Guy DeRose, Thomas L Forbes, et al.Journal of Dairy Science|April 25, 2017
Effects of prepartum dietary cation-anion difference on aspects of peripartum mineral and energy metabolism and performance of multiparous Holstein cowsB M Leno, C M Ryan, T Stokol, et al.Drug and Alcohol Dependence|April 30, 2015
Utilizing mHealth methods to identify patterns of high risk illicit drug useBeth S Linas, Carl Latkin, Andrew Genz, et al.AIDS (London, England)|October 20, 2012
Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug usersTsung-chieh Fu, Ryan P Westergaard, Bryan Lau, et al.Pageof 108